Biogen (BIIB) Price to Earnings (2009 - 2026)

Biogen has reported Price to Earnings for 18 years, with the latest figure at 327.42 in Q2 2026.

• On a quarterly basis, Price to Earnings rose 1028.79% year-over-year to 327.42 in Q2 2026; TTM through Jun 2026 was 38.25, a 217.93% increase from a year earlier, with the FY2025 full-year figure at 19.98, up 46.29% from the prior year.
• Price to Earnings was 327.42 for Q2 2026 at Biogen, up from 84.71 in the prior quarter.
• The five-year high for Price to Earnings was 327.42 in Q2 2026, with the low at 545.25 in Q3 2023.
• Average Price to Earnings over 5 years is 21.48, with a median of 72.64 recorded in 2022.
• The sharpest annual moves came in 2023 and 2026: Price to Earnings sank 1709.43% in 2023, then soared 1028.79% in 2026.
• Over 5 years, Price to Earnings stood at 72.57 in 2022, then jumped by 107.59% to 150.65 in 2023, then slumped by 44.51% to 83.6 in 2024, then sank by 731.98% to 528.33 in 2025, then surged by 161.97% to 327.42 in 2026.
• The last three Price to Earnings figures came in at 327.42 (Q2 2026), 84.71 (Q1 2026), and 528.33 (Q4 2025), per Business Quant data.